Guru Ownership Trend
Guru Analysis for TG Therapeutics, Inc. (TGTX)
TG Therapeutics, Inc. (TGTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.82 M.
Top institutional holders include Ray Dalio and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.64 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 100.6%. Conversely, Steven Cohen reduced exposure by 36.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for TG Therapeutics, Inc. (TGTX)
Major holders include Ray Dalio ($14.01 M), Steven Cohen ($6.9 M), Cliff Asness ($4.05 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 995,011 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.64 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited TGTX. The total reported sell value was $8.56 M.
Yes, 1 managers opened new positions in TGTX, and 3 increased their existing holdings. The total reported buy value was $6.93 M.
